| Product Code: ETC7548231 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Monkeypox Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Monkeypox Market Revenues & Volume, 2021 & 2031F |
3.3 India Monkeypox Market - Industry Life Cycle |
3.4 India Monkeypox Market - Porter's Five Forces |
3.5 India Monkeypox Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 India Monkeypox Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.7 India Monkeypox Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Monkeypox Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in awareness about zoonotic diseases and their prevention measures |
4.2.2 Growing urbanization leading to human-wildlife interactions |
4.2.3 Government initiatives to improve healthcare infrastructure and disease surveillance |
4.3 Market Restraints |
4.3.1 Lack of specific treatment or vaccine for monkeypox |
4.3.2 Limited research and development activities focused on monkeypox |
4.3.3 Challenges in early detection and diagnosis of monkeypox cases |
5 India Monkeypox Market Trends |
6 India Monkeypox Market, By Types |
6.1 India Monkeypox Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 India Monkeypox Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 India Monkeypox Market Revenues & Volume, By Cidofovir, 2021- 2031F |
6.1.4 India Monkeypox Market Revenues & Volume, By Brincidofovir, 2021- 2031F |
6.1.5 India Monkeypox Market Revenues & Volume, By Tecovirimat, 2021- 2031F |
6.1.6 India Monkeypox Market Revenues & Volume, By Vaccinia ImmuneGlobulin, 2021- 2031F |
6.2 India Monkeypox Market, By End users |
6.2.1 Overview and Analysis |
6.2.2 India Monkeypox Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.3 India Monkeypox Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.4 India Monkeypox Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Monkeypox Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Monkeypox Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.3.3 India Monkeypox Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.4 India Monkeypox Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 India Monkeypox Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.6 India Monkeypox Market Revenues & Volume, By Others, 2021- 2031F |
7 India Monkeypox Market Import-Export Trade Statistics |
7.1 India Monkeypox Market Export to Major Countries |
7.2 India Monkeypox Market Imports from Major Countries |
8 India Monkeypox Market Key Performance Indicators |
8.1 Number of research studies or clinical trials focused on monkeypox |
8.2 Percentage of healthcare professionals trained in monkeypox diagnosis and management |
8.3 Rate of adoption of preventive measures such as vaccination and hygiene practices among at-risk populations |
9 India Monkeypox Market - Opportunity Assessment |
9.1 India Monkeypox Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 India Monkeypox Market Opportunity Assessment, By End users, 2021 & 2031F |
9.3 India Monkeypox Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Monkeypox Market - Competitive Landscape |
10.1 India Monkeypox Market Revenue Share, By Companies, 2024 |
10.2 India Monkeypox Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here